• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Chemotherapy for advanced epidermoid carcinoma of the esophagus with single-agent cisplatin: final report on a Southwest Oncology Group study.

作者信息

Panettiere F J, Leichman L P, Tilchen E J, Chen T T

出版信息

Cancer Treat Rep. 1984 Jul-Aug;68(7-8):1023-4.

PMID:6540144
Abstract
摘要

相似文献

1
Chemotherapy for advanced epidermoid carcinoma of the esophagus with single-agent cisplatin: final report on a Southwest Oncology Group study.单药顺铂治疗晚期食管鳞状细胞癌的化疗：西南肿瘤协作组研究的最终报告
Cancer Treat Rep. 1984 Jul-Aug;68(7-8):1023-4.
2
Cis-diamminedichloride platinum(II), an effective agent in the treatment of epidermoid carcinoma of the esophagus. A preliminary report of an ongoing Southwest Oncology Group study.顺二氯二氨合铂（II），一种治疗食管鳞状细胞癌的有效药物。西南肿瘤学组一项正在进行的研究的初步报告。
Cancer Clin Trials. 1981;4(1):29-31.
3
Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).顺铂与5-氟尿嘧啶同步放疗用于晚期食管鳞状细胞癌的II期研究：日本食管癌肿瘤学组（JEOG）/日本临床肿瘤学会试验（JCOG9516）
Jpn J Clin Oncol. 2004 Oct;34(10):615-9. doi: 10.1093/jjco/hyh107.
4
A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report.一项针对局限性食管癌患者的外照射放疗、近距离放疗及同步化疗的I/II期研究（放射治疗肿瘤学组研究9207）：最终报告
Cancer. 2000 Mar 1;88(5):988-95.
5
5-Fluorouracil and cisplatin as palliative treatment of advanced oesophageal squamous cell carcinoma. A multicentre randomised controlled trial. The French Associations for Surgical Research.5-氟尿嘧啶和顺铂用于晚期食管鳞状细胞癌的姑息治疗。一项多中心随机对照试验。法国外科研究协会
Eur J Surg. 1998 Nov;164(11):849-57. doi: 10.1080/110241598750005273.
6
Phase II evaluation of cisplatin in squamous carcinoma of the esophagus: a Southeastern Cancer Study Group trial.顺铂用于食管癌鳞状细胞癌的II期评估：一项东南癌症研究组试验
Cancer Treat Rep. 1985 Dec;69(12):1457-8.
7
Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.一项针对局部晚期食管肿瘤进行新辅助化疗后行食管切除术的II期试验的长期结果。
Ann Thorac Surg. 2008 Jun;85(6):1930-6; discussion 1936-7. doi: 10.1016/j.athoracsur.2008.01.097.
8
cis-Dichlorodiammineplatinum(II) in the treatment of esophageal carcinoma.
Cancer Treat Rep. 1980 Apr-May;64(4-5):709-11.
9
Evaluation of single-agent cisplatin in the management of non-small cell carcinoma of the lung: a Southwest Oncology Group Study.单药顺铂治疗非小细胞肺癌的评估：西南肿瘤协作组研究
Cancer Treat Rep. 1983 Apr;67(4):399-400.
10
Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma.多疗程紫杉醇和顺铂联合5-氟尿嘧啶及亚叶酸钙用于转移性或复发性食管鳞状细胞癌患者的治疗
Anticancer Drugs. 2007 Jul;18(6):703-8. doi: 10.1097/CAD.0b013e328051b3a3.

引用本文的文献

1
Inhibition of human esophageal squamous cell carcinomas by targeted silencing of tumor enhancer genes: an overview.靶向沉默肿瘤增强子基因抑制人食管鳞癌细胞：概述。
Cancer Biol Med. 2014 Jun;11(2):78-85. doi: 10.7497/j.issn.2095-3941.2014.02.002.
2
BRCA1 mRNA expression as a predictive and prognostic marker in advanced esophageal squamous cell carcinoma treated with cisplatin- or docetaxel-based chemotherapy/chemoradiotherapy.BRCA1 mRNA 表达作为预测和预后标志物在接受顺铂或多西紫杉醇为基础的化疗/放化疗治疗的晚期食管鳞状细胞癌中的应用。
PLoS One. 2013;8(1):e52589. doi: 10.1371/journal.pone.0052589. Epub 2013 Jan 9.
3
Phase II Trial of Docetaxel and Carboplatin in Patients With Advanced Squamous Carcinoma of the Esophagus (E2298): A Trial of the Eastern Cooperative Oncology Group.
多西他赛与卡铂治疗晚期食管鳞癌的II期试验（E2298）：东部肿瘤协作组的一项试验
Gastrointest Cancer Res. 2011 Jan;4(1):9-14.
4
Gemcitabine and cisplatin for patients with metastatic or recurrent esophageal carcinoma: a Southwest Oncology Group Study.吉西他滨和顺铂用于转移性或复发性食管癌患者：一项西南肿瘤协作组研究
Invest New Drugs. 2004 Jan;22(1):91-7. doi: 10.1023/b:drug.0000006179.20974.af.
5
Combined modality therapy for esophageal cancer.
Curr Oncol Rep. 1999;1(2):149-54. doi: 10.1007/s11912-999-0026-2.
6
Cisplatin and etoposide in oesophageal cancer: a phase II study. Rotterdam Oesophageal Tumour Study Group.顺铂和依托泊苷用于食管癌治疗：一项II期研究。鹿特丹食管癌研究组
Br J Cancer. 1996 Sep;74(6):980-4. doi: 10.1038/bjc.1996.469.
7
Phase II study of single-agent etoposide in patients with metastatic squamous-cell carcinoma of the esophagus.依托泊苷单药治疗转移性食管鳞状细胞癌患者的II期研究。
Cancer Chemother Pharmacol. 1992;29(4):321-2. doi: 10.1007/BF00685952.